Epidemiology, Clinical Presentation and Treatment of Non-Hepatic Hyperammonemia in ICU COVID-19 Patients

(1) Background: Although COVID-19 is largely a respiratory disease, it is actually a systemic disease that has a wide range of effects that are not yet fully known. The aim of this study was to determine the incidence, predictors and outcome of non-hepatic hyperammonemia (NHH) in COVID-19 in intensi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Nardi Tetaj, Giulia Valeria Stazi, Maria Cristina Marini, Gabriele Garotto, Donatella Busso, Silvana Scarcia, Ilaria Caravella, Manuela Macchione, Giada De Angelis, Rachele Di Lorenzo, Alessandro Carucci, Alessandro Capone, Andrea Antinori, Fabrizio Palmieri, Gianpiero D’Offizi, Fabrizio Taglietti, Stefania Ianniello, Paolo Campioni, Francesco Vaia, Emanuele Nicastri, Enrico Girardi, Luisa Marchioni, on behalf of ICU COVID-19 Study Group
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2022-05-01
Serija:Journal of Clinical Medicine
Teme:
COVID-19
Coronavirus disease
intensive care unit
non-hepatic hyperammonemia
Online pristup:https://www.mdpi.com/2077-0383/11/9/2592
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items